首页 > 最新文献

Lancet Global Health最新文献

英文 中文
Social and health disparities associated with healthy brain ageing in Brazil and in other Latin American countries.
IF 19.9 1区 医学 Q1 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2025-02-01 DOI: 10.1016/S2214-109X(24)00451-0
Lucas U Da Ros, Wyllians Vendramini Borelli, Cristiano Schaffer Aguzzoli, Marco Antônio De Bastiani, Lucas Porcello Schilling, Hernando Santamaria-Garcia, Tharick A Pascoal, Pedro Rosa-Neto, Diogo O Souza, Jaderson Costa da Costa, Agustin Ibañez, Claudia Kimie Suemoto, Eduardo R Zimmer

Background: Latin American countries present major health-related inequities due to historical, cultural, and social aspects. Recent evidence highlights that factors related to social and health disparities outweigh classic demographic factors in determining healthy brain aging in these populations. However, these analyses have not been conducted with the Brazilian population, the largest and most ethnically diverse population in Latin America.

Methods: Here, we evaluated demographic, social, and health factors for healthy brain ageing using a machine learning model in a Brazilian population-based cohort (n=9412) and in additional cohorts from other Latin American countries, including Colombia (n=23 694), Chile (n=1301), Ecuador (n=5235), and Uruguay (n=1450).

Findings: In the Brazilian population and other Latin American countries, social and health disparities were more influential than demographic factors for cognition and functional ability. Uniquely in Brazil, education emerged as the primary risk factor impacting cognitive outcomes, diverging from other Latin American countries where mental health symptoms played more prominent roles. In terms of functional ability, Brazil displayed a distinct pattern, with mental health symptoms identified as the primary contributing factor.

Interpretation: Our findings indicate that Brazil converges with other Latin American countries to show that heterogeneous factors impacted more than demographic factors, but also showed a unique set of health factors when compared with other Latin American countries. Therefore, our study emphasises that social and health disparity factors are relevant predictors of healthy brain ageing in Latin America, but population-specific analyses are necessary to identify the specific risk profiles of each country.

Funding: None.

Translations: For the Portuguese and Spanish translations of the abstract see Supplementary Materials section.

{"title":"Social and health disparities associated with healthy brain ageing in Brazil and in other Latin American countries.","authors":"Lucas U Da Ros, Wyllians Vendramini Borelli, Cristiano Schaffer Aguzzoli, Marco Antônio De Bastiani, Lucas Porcello Schilling, Hernando Santamaria-Garcia, Tharick A Pascoal, Pedro Rosa-Neto, Diogo O Souza, Jaderson Costa da Costa, Agustin Ibañez, Claudia Kimie Suemoto, Eduardo R Zimmer","doi":"10.1016/S2214-109X(24)00451-0","DOIUrl":"10.1016/S2214-109X(24)00451-0","url":null,"abstract":"<p><strong>Background: </strong>Latin American countries present major health-related inequities due to historical, cultural, and social aspects. Recent evidence highlights that factors related to social and health disparities outweigh classic demographic factors in determining healthy brain aging in these populations. However, these analyses have not been conducted with the Brazilian population, the largest and most ethnically diverse population in Latin America.</p><p><strong>Methods: </strong>Here, we evaluated demographic, social, and health factors for healthy brain ageing using a machine learning model in a Brazilian population-based cohort (n=9412) and in additional cohorts from other Latin American countries, including Colombia (n=23 694), Chile (n=1301), Ecuador (n=5235), and Uruguay (n=1450).</p><p><strong>Findings: </strong>In the Brazilian population and other Latin American countries, social and health disparities were more influential than demographic factors for cognition and functional ability. Uniquely in Brazil, education emerged as the primary risk factor impacting cognitive outcomes, diverging from other Latin American countries where mental health symptoms played more prominent roles. In terms of functional ability, Brazil displayed a distinct pattern, with mental health symptoms identified as the primary contributing factor.</p><p><strong>Interpretation: </strong>Our findings indicate that Brazil converges with other Latin American countries to show that heterogeneous factors impacted more than demographic factors, but also showed a unique set of health factors when compared with other Latin American countries. Therefore, our study emphasises that social and health disparity factors are relevant predictors of healthy brain ageing in Latin America, but population-specific analyses are necessary to identify the specific risk profiles of each country.</p><p><strong>Funding: </strong>None.</p><p><strong>Translations: </strong>For the Portuguese and Spanish translations of the abstract see Supplementary Materials section.</p>","PeriodicalId":48783,"journal":{"name":"Lancet Global Health","volume":"13 2","pages":"e277-e284"},"PeriodicalIF":19.9,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143075685","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The prevalence of hypoxaemia in paediatric and adult patients in health-care facilities in low-income and middle-income countries: a systematic review and meta-analysis.
IF 19.9 1区 医学 Q1 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2025-02-01 DOI: 10.1016/S2214-109X(24)00469-8
Hamish R Graham, Esrat Jahan, Rami Subhi, Farhia Azrin, Jaclyn R Maher, Jasmine L Miller, Ahmed Ehsanur Rahman, Felix Lam

Background: Hypoxaemia (low oxygen saturation in blood) is a key predictor of in-hospital mortality, affecting people of all ages with many different conditions. Early detection and treatment of hypoxaemia are critical, but there are few data to quantify hypoxaemia burden outside the child pneumonia population. We aimed to estimate hypoxaemia prevalence for adults and children with acute illness attending health facilities in low-income and middle-income countries (LMICs).

Methods: We conducted a systematic review and meta-analysis, searching MEDLINE, PubMed, Embase, Cumulated Index in Nursing and Allied Health Literature, Index Medicus, and Google Scholar for studies reporting hypoxaemia prevalence among patients attending health facilities. We included articles with original data on peripheral blood oxygen saturation (SpO2), from an LMIC, published between Jan 1, 1998, and Jan 10, 2023. We included studies in acutely unwell people of any age and with any condition, but excluded those admitted to intensive care units, receiving perioperative care, or attending hospital for preventive or chronic care. We assessed study quality using Joanna Briggs Institute's Checklist for Prevalence Studies. Two reviewers independently conducted title and abstract screening, full-text review, data extraction, and quality assessment, requesting summary data from authors. We reported pooled prevalence of hypoxaemia (typically defined as SpO2 <90%) overall and by condition, using a random-effects meta-analysis model. This study is registered with PROSPERO, CRD42019136622.

Findings: We identified 9173 unique records from searches and included 213 in meta-analyses involving 601 757 participants. The majority of studies were from the World Bank regions of sub-Saharan Africa (108 [51%] of 213) or south Asia (58 [27%]). The pooled prevalence of hypoxaemia among admitted patients was 24·5% (95% CI 19·9-29·4) for neonates (aged 0-28 days), 12·1% (10·0-14·4) for children (aged 1 month-17 years), and 10·8% (4·9-18·7) for adults (aged ≥18 years). Hypoxaemia prevalence was highest in neonatal and primary respiratory conditions but still common in many other conditions. Hypoxaemia was associated with 4·84 (95% CI 4·11-5·69) times higher odds of death than no hypoxaemia.

Interpretation: Hypoxaemia is common across all age groups and a range of primary respiratory and other critical illnesses and is strongly associated with death. These estimates will inform oxygen-related strategies and programmes, and integration of pulse oximetry and oxygen into clinical guidelines, service structures, and strategies for maternal, neonatal, child, adolescent, and adult health.

Funding: Bill & Melinda Gates Foundation, the ELMA Foundation, and Unitaid.

{"title":"The prevalence of hypoxaemia in paediatric and adult patients in health-care facilities in low-income and middle-income countries: a systematic review and meta-analysis.","authors":"Hamish R Graham, Esrat Jahan, Rami Subhi, Farhia Azrin, Jaclyn R Maher, Jasmine L Miller, Ahmed Ehsanur Rahman, Felix Lam","doi":"10.1016/S2214-109X(24)00469-8","DOIUrl":"10.1016/S2214-109X(24)00469-8","url":null,"abstract":"<p><strong>Background: </strong>Hypoxaemia (low oxygen saturation in blood) is a key predictor of in-hospital mortality, affecting people of all ages with many different conditions. Early detection and treatment of hypoxaemia are critical, but there are few data to quantify hypoxaemia burden outside the child pneumonia population. We aimed to estimate hypoxaemia prevalence for adults and children with acute illness attending health facilities in low-income and middle-income countries (LMICs).</p><p><strong>Methods: </strong>We conducted a systematic review and meta-analysis, searching MEDLINE, PubMed, Embase, Cumulated Index in Nursing and Allied Health Literature, Index Medicus, and Google Scholar for studies reporting hypoxaemia prevalence among patients attending health facilities. We included articles with original data on peripheral blood oxygen saturation (SpO<sub>2</sub>), from an LMIC, published between Jan 1, 1998, and Jan 10, 2023. We included studies in acutely unwell people of any age and with any condition, but excluded those admitted to intensive care units, receiving perioperative care, or attending hospital for preventive or chronic care. We assessed study quality using Joanna Briggs Institute's Checklist for Prevalence Studies. Two reviewers independently conducted title and abstract screening, full-text review, data extraction, and quality assessment, requesting summary data from authors. We reported pooled prevalence of hypoxaemia (typically defined as SpO<sub>2</sub> <90%) overall and by condition, using a random-effects meta-analysis model. This study is registered with PROSPERO, CRD42019136622.</p><p><strong>Findings: </strong>We identified 9173 unique records from searches and included 213 in meta-analyses involving 601 757 participants. The majority of studies were from the World Bank regions of sub-Saharan Africa (108 [51%] of 213) or south Asia (58 [27%]). The pooled prevalence of hypoxaemia among admitted patients was 24·5% (95% CI 19·9-29·4) for neonates (aged 0-28 days), 12·1% (10·0-14·4) for children (aged 1 month-17 years), and 10·8% (4·9-18·7) for adults (aged ≥18 years). Hypoxaemia prevalence was highest in neonatal and primary respiratory conditions but still common in many other conditions. Hypoxaemia was associated with 4·84 (95% CI 4·11-5·69) times higher odds of death than no hypoxaemia.</p><p><strong>Interpretation: </strong>Hypoxaemia is common across all age groups and a range of primary respiratory and other critical illnesses and is strongly associated with death. These estimates will inform oxygen-related strategies and programmes, and integration of pulse oximetry and oxygen into clinical guidelines, service structures, and strategies for maternal, neonatal, child, adolescent, and adult health.</p><p><strong>Funding: </strong>Bill & Melinda Gates Foundation, the ELMA Foundation, and Unitaid.</p>","PeriodicalId":48783,"journal":{"name":"Lancet Global Health","volume":"13 2","pages":"e222-e231"},"PeriodicalIF":19.9,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11783038/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143075882","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Correction to Lancet Glob Health 2024; 12: e1232-43. 《柳叶刀全球健康》2024年更正;12: e1232-43。
IF 19.9 1区 医学 Q1 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2025-02-01 Epub Date: 2024-12-06 DOI: 10.1016/S2214-109X(24)00533-3
{"title":"Correction to Lancet Glob Health 2024; 12: e1232-43.","authors":"","doi":"10.1016/S2214-109X(24)00533-3","DOIUrl":"10.1016/S2214-109X(24)00533-3","url":null,"abstract":"","PeriodicalId":48783,"journal":{"name":"Lancet Global Health","volume":" ","pages":"e202"},"PeriodicalIF":19.9,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11790337/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142802910","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Africa's mpox strategic preparedness and response plan: a coordinated continental effort to boost health security. 非洲水痘战略准备和应对计划:非洲大陆协调努力,促进健康安全。
IF 19.9 1区 医学 Q1 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2025-02-01 Epub Date: 2024-10-29 DOI: 10.1016/S2214-109X(24)00464-9
Nicaise Ndembi, Ngashi Ngongo, Moréniké Oluwátóyìn Foláyan, Jean Marie Yameogo, Fiona Braka, Salam Abdou Gueye, Moeti Matshidiso, Jean Kaseya
{"title":"Africa's mpox strategic preparedness and response plan: a coordinated continental effort to boost health security.","authors":"Nicaise Ndembi, Ngashi Ngongo, Moréniké Oluwátóyìn Foláyan, Jean Marie Yameogo, Fiona Braka, Salam Abdou Gueye, Moeti Matshidiso, Jean Kaseya","doi":"10.1016/S2214-109X(24)00464-9","DOIUrl":"10.1016/S2214-109X(24)00464-9","url":null,"abstract":"","PeriodicalId":48783,"journal":{"name":"Lancet Global Health","volume":" ","pages":"e191-e193"},"PeriodicalIF":19.9,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142564971","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
2022 Sudan virus disease outbreak in Uganda: temporal variations in transmission.
IF 19.9 1区 医学 Q1 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2025-02-01 DOI: 10.1016/S2214-109X(24)00555-2
Bianca de Padua, Andrei R Akhmetzhanov, Robin N Thompson
{"title":"2022 Sudan virus disease outbreak in Uganda: temporal variations in transmission.","authors":"Bianca de Padua, Andrei R Akhmetzhanov, Robin N Thompson","doi":"10.1016/S2214-109X(24)00555-2","DOIUrl":"https://doi.org/10.1016/S2214-109X(24)00555-2","url":null,"abstract":"","PeriodicalId":48783,"journal":{"name":"Lancet Global Health","volume":"13 2","pages":"e201"},"PeriodicalIF":19.9,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143076038","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Eliminate prescribers' uncertainty to catalyse the impact of vaccines on antibiotic use.
IF 19.9 1区 医学 Q1 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2025-01-28 DOI: 10.1016/S2214-109X(25)00018-X
Brecht Ingelbeen, Nandini Sreenivasan, Annick Lenglet
{"title":"Eliminate prescribers' uncertainty to catalyse the impact of vaccines on antibiotic use.","authors":"Brecht Ingelbeen, Nandini Sreenivasan, Annick Lenglet","doi":"10.1016/S2214-109X(25)00018-X","DOIUrl":"https://doi.org/10.1016/S2214-109X(25)00018-X","url":null,"abstract":"","PeriodicalId":48783,"journal":{"name":"Lancet Global Health","volume":" ","pages":""},"PeriodicalIF":19.9,"publicationDate":"2025-01-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143075976","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Rethinking pandemic metrics: are composite indices enough? 重新思考流行病指标:综合指数足够吗?
IF 34.3 1区 医学 Q1 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2025-01-17 DOI: 10.1016/s2214-109x(25)00002-6
Clara Marín-Carballo,Bach Tran,Shenglan Tang,Michael Merson,Taufique Joarder
{"title":"Rethinking pandemic metrics: are composite indices enough?","authors":"Clara Marín-Carballo,Bach Tran,Shenglan Tang,Michael Merson,Taufique Joarder","doi":"10.1016/s2214-109x(25)00002-6","DOIUrl":"https://doi.org/10.1016/s2214-109x(25)00002-6","url":null,"abstract":"","PeriodicalId":48783,"journal":{"name":"Lancet Global Health","volume":"45 1","pages":""},"PeriodicalIF":34.3,"publicationDate":"2025-01-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142991812","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Estimating the epidemiological and economic impact of providing nutritional care for tuberculosis-affected households across India: a modelling study. 估计为印度受结核病影响的家庭提供营养护理的流行病学和经济影响:一项模型研究。
IF 34.3 1区 医学 Q1 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2025-01-14 DOI: 10.1016/s2214-109x(24)00505-9
Christopher Finn McQuaid,Rebecca A Clark,Richard G White,Roel Bakker,Peter Alexander,Roslyn Henry,Banurekha Velayutham,Malaisamy Muniyandi,Pranay Sinha,Madhavi Bhargava,Anurag Bhargava,Rein M G J Houben
BACKGROUNDApproximately 20% of global tuberculosis incidence is attributable to undernutrition, increasing to more than a third in India. Targeting nutritional interventions to tuberculosis-affected households is a policy priority, but understanding of epidemiological and economic impacts is limited. We aimed to estimate the population-level epidemiological and economic effect of such an intervention.METHODSWe used a previously published, age-stratified, compartmental transmission model of tuberculosis in India, and incorporated explicit BMI strata linked to disease progression and treatment outcomes. We used results from a recent trial of an intervention in which nutritional support in the form of food baskets was provided to people initiating tuberculosis treatment and to their household contacts (1200 kcal for patients and 750 kcal for contacts) to inform estimates of the impact and costs of nutritional support. We estimated the numbers of cases of tuberculosis disease and deaths due to tuberculosis disease that could be averted from 2023 to 2035 under the intervention scenario.FINDINGSCompared with a baseline with no nutritional intervention, at 50% coverage of adults on tuberculosis treatment and their households (around 23% of households affected by incident tuberculosis in India), providing the nutritional support intervention could prevent 361 200 (95% uncertainty interval 318 000-437 700) tuberculosis deaths and 880 700 (802 700-974 900) disease episodes from 2023 to 2035. This would be equivalent to averting approximately 4·6% (4·2-5·5) tuberculosis deaths and 2·2% (2·1-2·4) tuberculosis episodes. The additional health system cost would be US$1349 million (1221-1492), with an incremental cost-effectiveness ratio of $167 (147-187) per disability-adjusted life-year averted. The median number of households needed to treat to prevent one tuberculosis death was 24·4 and to prevent one tuberculosis case was 10·0.INTERPRETATIONA nutritional intervention for tuberculosis-affected households could avert a substantial amount of tuberculosis disease and death in India, and would be highly likely to be cost-effective on the basis of the tuberculosis-specific benefits alone.FUNDINGNone.TRANSLATIONSFor the Bangla and Hindi translations of the abstract see Supplementary Materials section.
全球大约20%的结核病发病率是由营养不良引起的,在印度这一比例增加到三分之一以上。针对受结核病影响的家庭进行营养干预是一项政策重点,但对流行病学和经济影响的了解有限。我们的目的是估计这种干预的人口水平的流行病学和经济影响。方法:我们使用了先前发表的印度结核病年龄分层室间传播模型,并纳入了与疾病进展和治疗结果相关的明确BMI分层。我们使用了最近一项干预试验的结果,该试验以食品篮的形式向开始结核病治疗的人及其家庭接触者(患者1200千卡,接触者750千卡)提供营养支持,以评估营养支持的影响和成本。我们估计了在干预方案下,从2023年到2035年可以避免的结核病病例和结核病死亡人数。研究结果:与不进行营养干预的基线相比,在接受结核病治疗的成年人及其家庭覆盖率达到50%时(印度受意外结核病影响的家庭约占23%),从2023年至2035年,提供营养支持干预可预防36200例(95%不确定区间318 000-437 700)结核病死亡和880 700例(8027 700-974 900)疾病发作。这将相当于避免约4.6%(4.2 -5)的结核病死亡和2.2%(2.1 - 4)的结核病发作。额外的卫生系统费用将为1.349亿美元(1221-1492),每个避免的残疾调整生命年的增量成本效益比为167美元(147-187)。预防1例结核病死亡所需治疗的家庭中位数为24.4户,预防1例结核病病例所需治疗的家庭中位数为10.0户。在印度,对受结核病影响的家庭进行营养干预可以避免大量的结核病发病率和死亡率,并且仅从结核病特有的益处来看,极有可能具有成本效益。资金无。翻译摘要的孟加拉语和印地语翻译见补充材料部分。
{"title":"Estimating the epidemiological and economic impact of providing nutritional care for tuberculosis-affected households across India: a modelling study.","authors":"Christopher Finn McQuaid,Rebecca A Clark,Richard G White,Roel Bakker,Peter Alexander,Roslyn Henry,Banurekha Velayutham,Malaisamy Muniyandi,Pranay Sinha,Madhavi Bhargava,Anurag Bhargava,Rein M G J Houben","doi":"10.1016/s2214-109x(24)00505-9","DOIUrl":"https://doi.org/10.1016/s2214-109x(24)00505-9","url":null,"abstract":"BACKGROUNDApproximately 20% of global tuberculosis incidence is attributable to undernutrition, increasing to more than a third in India. Targeting nutritional interventions to tuberculosis-affected households is a policy priority, but understanding of epidemiological and economic impacts is limited. We aimed to estimate the population-level epidemiological and economic effect of such an intervention.METHODSWe used a previously published, age-stratified, compartmental transmission model of tuberculosis in India, and incorporated explicit BMI strata linked to disease progression and treatment outcomes. We used results from a recent trial of an intervention in which nutritional support in the form of food baskets was provided to people initiating tuberculosis treatment and to their household contacts (1200 kcal for patients and 750 kcal for contacts) to inform estimates of the impact and costs of nutritional support. We estimated the numbers of cases of tuberculosis disease and deaths due to tuberculosis disease that could be averted from 2023 to 2035 under the intervention scenario.FINDINGSCompared with a baseline with no nutritional intervention, at 50% coverage of adults on tuberculosis treatment and their households (around 23% of households affected by incident tuberculosis in India), providing the nutritional support intervention could prevent 361 200 (95% uncertainty interval 318 000-437 700) tuberculosis deaths and 880 700 (802 700-974 900) disease episodes from 2023 to 2035. This would be equivalent to averting approximately 4·6% (4·2-5·5) tuberculosis deaths and 2·2% (2·1-2·4) tuberculosis episodes. The additional health system cost would be US$1349 million (1221-1492), with an incremental cost-effectiveness ratio of $167 (147-187) per disability-adjusted life-year averted. The median number of households needed to treat to prevent one tuberculosis death was 24·4 and to prevent one tuberculosis case was 10·0.INTERPRETATIONA nutritional intervention for tuberculosis-affected households could avert a substantial amount of tuberculosis disease and death in India, and would be highly likely to be cost-effective on the basis of the tuberculosis-specific benefits alone.FUNDINGNone.TRANSLATIONSFor the Bangla and Hindi translations of the abstract see Supplementary Materials section.","PeriodicalId":48783,"journal":{"name":"Lancet Global Health","volume":"20 1","pages":""},"PeriodicalIF":34.3,"publicationDate":"2025-01-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142989719","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Strengthening nutritional care to end tuberculosis in India. 在印度加强营养保健以消除结核病。
IF 34.3 1区 医学 Q1 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2025-01-14 DOI: 10.1016/s2214-109x(24)00554-0
Nandini Sharma,Saurav Basu
{"title":"Strengthening nutritional care to end tuberculosis in India.","authors":"Nandini Sharma,Saurav Basu","doi":"10.1016/s2214-109x(24)00554-0","DOIUrl":"https://doi.org/10.1016/s2214-109x(24)00554-0","url":null,"abstract":"","PeriodicalId":48783,"journal":{"name":"Lancet Global Health","volume":"37 1","pages":""},"PeriodicalIF":34.3,"publicationDate":"2025-01-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142989656","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Progress in reducing socioeconomic inequalities in the use of modern contraceptives in 48 focus countries as part of the FP2030 initiative between 1990 and 2020: a population-based analysis. 1990年至2020年期间48个重点国家在减少现代避孕药具使用方面的社会经济不平等方面取得的进展(作为2030年可持续发展计划的一部分):基于人口的分析。
IF 19.9 1区 医学 Q1 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2025-01-01 DOI: 10.1016/S2214-109X(24)00424-8
Carolina Cardona, Jean Christophe Rusatira, Carolina Salmeron, Michelle Martinez-Baack, Jose G Rimon, Philip Anglewicz, Saifuddin Ahmed

Background: Despite increases in modern contraception use, socioeconomic inequalities in family planning persist. In this study, we aimed to measure progress in reducing socioeconomic inequalities in modern contraceptive prevalence rate (mCPR) and demand for family planning satisfied by modern methods (mDFPS) in 48 countries as part of the Family Planning 2030 (FP2030) initiative between 1990 and 2020 for which Demographic and Health Survey data were available.

Methods: We analysed two rounds of Demographic and Health Survey data per country. Changes in concentration indices between two survey rounds were compared to measure reductions in overall socioeconomic-related inequalities in modern contraceptive use. Poisson regression models were used to measure the adjusted average annual rate of change across wealth quintiles.

Findings: In this population-based analysis study, all countries reduced socioeconomic-related inequalities in modern contraceptive use among in-union women of reproductive age (15-49 years) during the observed 30-year period. On average, mCPR increased at an annual rate of 2·1% (95% CI 2·1-2·2), and the rate of increase for the poorest women was 3·1% (3·0-3·2), which outpaced the rate of increase for the richest women of 1·3% (1·3-1·4%). The pattern of progress was similar for mDFPS, but at a slower pace. Overall, levels of mCPR and mDFPS increased, and socioeconomic-related inequalities were reduced during this period.

Interpretation: Substantial progress has been made in reducing socioeconomic-related inequalities in family planning across the 48 studied countries, which account for 86% of the population of the 82 FP2030 initiative countries. During the past three decades, poorer women have seen greater improvements in modern contraceptive use and demand satisfaction compared with richer women. As contraceptive prevalence rates are near their maximum, it is crucial to ensure marginalised and vulnerable groups are not left behind.

Funding: Bill & Melinda Gates Foundation.

Translations: For the French and Spanish translations of the abstract see Supplementary Materials section.

背景:尽管现代避孕措施的使用有所增加,但计划生育方面的社会经济不平等仍然存在。在这项研究中,我们的目的是衡量在减少社会经济不平等方面的进展,现代避孕普及率(mCPR)和现代方法满足的计划生育需求(mDFPS)在48个国家,作为1990年至2020年计划生育(FP2030)倡议的一部分,人口与健康调查数据可用。方法:我们分析了每个国家的两轮人口与健康调查数据。比较了两轮调查之间浓度指数的变化,以衡量现代避孕药具使用中与社会经济有关的总体不平等现象的减少情况。泊松回归模型被用来衡量跨财富五分位数调整后的平均年变化率。研究结果:在这项基于人口的分析研究中,在观察的30年期间,所有国家都减少了与社会经济相关的育龄妇女(15-49岁)使用现代避孕药具的不平等现象。平均而言,mCPR以每年2.1%的速度增长(95% CI为2.1 -2),最贫穷妇女的增长率为3.1%(3.3 - 3.2),超过了最富有妇女1.3%(1.3 - 4%)的增长率。进度模式与mDFPS类似,但速度较慢。总体而言,在此期间,mCPR和mDFPS的水平有所上升,与社会经济相关的不平等现象有所减少。解读:48个被研究的国家在减少计划生育方面的社会经济不平等方面取得了实质性进展,这些国家占82个FP2030倡议国家人口的86%。在过去三十年中,与较富裕的妇女相比,较贫穷的妇女在现代避孕药具的使用和需求满意度方面取得了更大的进步。由于避孕普及率已接近最高点,确保边缘化和弱势群体不被抛在后面至关重要。资助:比尔及梅琳达·盖茨基金会。翻译:关于摘要的法语和西班牙语翻译,请参见补充材料部分。
{"title":"Progress in reducing socioeconomic inequalities in the use of modern contraceptives in 48 focus countries as part of the FP2030 initiative between 1990 and 2020: a population-based analysis.","authors":"Carolina Cardona, Jean Christophe Rusatira, Carolina Salmeron, Michelle Martinez-Baack, Jose G Rimon, Philip Anglewicz, Saifuddin Ahmed","doi":"10.1016/S2214-109X(24)00424-8","DOIUrl":"10.1016/S2214-109X(24)00424-8","url":null,"abstract":"<p><strong>Background: </strong>Despite increases in modern contraception use, socioeconomic inequalities in family planning persist. In this study, we aimed to measure progress in reducing socioeconomic inequalities in modern contraceptive prevalence rate (mCPR) and demand for family planning satisfied by modern methods (mDFPS) in 48 countries as part of the Family Planning 2030 (FP2030) initiative between 1990 and 2020 for which Demographic and Health Survey data were available.</p><p><strong>Methods: </strong>We analysed two rounds of Demographic and Health Survey data per country. Changes in concentration indices between two survey rounds were compared to measure reductions in overall socioeconomic-related inequalities in modern contraceptive use. Poisson regression models were used to measure the adjusted average annual rate of change across wealth quintiles.</p><p><strong>Findings: </strong>In this population-based analysis study, all countries reduced socioeconomic-related inequalities in modern contraceptive use among in-union women of reproductive age (15-49 years) during the observed 30-year period. On average, mCPR increased at an annual rate of 2·1% (95% CI 2·1-2·2), and the rate of increase for the poorest women was 3·1% (3·0-3·2), which outpaced the rate of increase for the richest women of 1·3% (1·3-1·4%). The pattern of progress was similar for mDFPS, but at a slower pace. Overall, levels of mCPR and mDFPS increased, and socioeconomic-related inequalities were reduced during this period.</p><p><strong>Interpretation: </strong>Substantial progress has been made in reducing socioeconomic-related inequalities in family planning across the 48 studied countries, which account for 86% of the population of the 82 FP2030 initiative countries. During the past three decades, poorer women have seen greater improvements in modern contraceptive use and demand satisfaction compared with richer women. As contraceptive prevalence rates are near their maximum, it is crucial to ensure marginalised and vulnerable groups are not left behind.</p><p><strong>Funding: </strong>Bill & Melinda Gates Foundation.</p><p><strong>Translations: </strong>For the French and Spanish translations of the abstract see Supplementary Materials section.</p>","PeriodicalId":48783,"journal":{"name":"Lancet Global Health","volume":"13 1","pages":"e38-e49"},"PeriodicalIF":19.9,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11659844/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142873276","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Lancet Global Health
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1